Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-26 @ 4:07 PM
Study NCT ID:
NCT01026233
Status:
COMPLETED
Last Update Posted:
2014-12-12
First Post:
2009-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cardiac Safety Study of Brentuximab Vedotin (SGN-35)
Sponsor:
Seagen Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-02
First Submit QC Date:
None
Study First Post Date:
2009-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-11
Last Update Post Date:
2014-12-12
Last Update Post Date Type:
ESTIMATED